Sun et al. (22) reported that a decreased expression of MARCO was associated with tumor progression and poor prognosis in hepatocellular carcinoma and Lundgren et al. (23) showed that high density of MARCO+ TAMs in certain subtypes of periampullary pancreatic cancer predicted shorter survival. Here, MARCO is linked to hepatocellular carcinoma.